PerkinElmer Expands Its OneSource(R) Laboratory Services with Acquisition of LabMetrix...

PerkinElmer Expands Its OneSource(R) Laboratory Services with Acquisition of LabMetrix Technologies

Brings Industry's Most Comprehensive Regulatory Compliance
Solutions to Customers
WALTHAM, Mass.--(Business Wire)--
PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences
and Photonics, today announced the acquisition of LabMetrix
Technologies, the largest independent provider of metrology-based
multi-vendor analytical instrument qualification solutions. The
acquisition of LabMetrix adds technology, tools, proven processes and
compliance expertise to PerkinElmer's growing suite of OneSource(R)
laboratory services, strengthening its support of customers in a wide
range of industries including pharmaceutical, medical device, food,
toy and other consumer goods. The terms of the deal were not
disclosed.

"This acquisition expands our support of customers in regulated
markets by combining metrology-based multi-vendor qualification
solutions with PerkinElmer's existing services capabilities," said
Robert F. Friel, president and chief executive officer, PerkinElmer.
"With the addition of LabMetrix's technology-assisted compliance
solution, we can provide customers with the most robust qualification
environment available for a broad range of instruments and
technologies in their labs, regardless of manufacturer."

Greater public attention on product safety coupled with customers'
increased need for improved scientific output continue to drive
greater demand for comprehensive regulatory compliance solutions. The
combination of LabMetrix's technology solutions with PerkinElmer's
existing OneSource offerings will make it significantly easier for
customers to demonstrate the accuracy of their analytical measurements
while helping drive down the cost of compliance through automation,
standardization and streamlined documentation. LabMetrix generated
revenues of approximately $5 million in 2007.

"We are excited by the opportunity to combine the strengths of
PerkinElmer's qualification capabilities with our patented solutions,"
said Serge Njamfa, president and chief executive officer, LabMetrix
Technologies. "For over twenty years, we have successfully qualified
thousands of analytical instruments. We look forward to combining our
proven technologies with PerkinElmer's outstanding global service
presence to offer customers the most comprehensive and cost-effective
services available from any supplier."

Factors Affecting Future Performance

This press release contains "forward-looking" statements within
the meaning of the Private Securities Litigation Reform Act of 1995,
including, but not limited to, statements relating to estimates and
projections of future earnings per share, cash flow, revenue growth
and other financial results, developments relating to our customers
and end-markets, and plans concerning business development
opportunities. Words such as "believes," "intends," "anticipates,"
"plans," "expects," "projects," "forecasts," "will" and similar
expressions, and references to guidance, are intended to identify
forward-looking statements. Such statements are based on management's
current assumptions and expectations and no assurances can be given
that our assumptions or expectations will prove to be correct. A
number of important risk factors could cause actual results to differ
materially from the results described, implied or projected in any
forward-looking statements. These factors include, without limitation:
(1) our failure to introduce new products in a timely manner; (2) our
ability to execute acquisitions and license technologies, or to
successfully integrate acquired businesses and licensed technologies
into our existing business or to make them profitable; (3) our failure
to protect adequately our intellectual property; (4) the loss of any
of our licenses or licensed rights; (5) our ability to compete
effectively; (6) fluctuation in our quarterly operating results and
our ability to adjust our operations to address unexpected changes;
(7) our ability to produce an adequate quantity of products to meet
our customers' demands; (8) our failure to maintain compliance with
applicable government regulations; (9) regulatory changes; (10) our
failure to comply with health care industry regulations; (11)
economic, political and other risks associated with foreign
operations; (12) our ability to retain key personnel; (13)
restrictions in our credit agreements; (14) our ability to realize the
full value of our intangible assets; and (15) other factors which we
describe under the caption "Risk Factors" in our most recent annual
report on Form 10-K and in our most recent quarterly report on Form
10-Q and in our other filings with the Securities and Exchange
Commission. We disclaim any intention or obligation to update any
forward-looking statements as a result of developments occurring after
the date of this press release.

PerkinElmer, Inc. is a global technology leader driving growth and
innovation in Health Sciences and Photonics markets to improve the
quality of life. The Company reported revenues of $1.8 billion in
2007, has 9,100 employees serving customers in more than 150
countries, and is a component of the S&P 500 Index. Additional
information is available through www.perkinelmer.com or
1-877-PKI-NYSE.

Investor Relations:
PerkinElmer, Inc.
Michael A. Lawless, 781-663-5659
or
Media Contact:
Brodeur Worldwide
Steve Marchant, 617-587-2864

Copyright Business Wire 2008